Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for GeneDx Holdings (WGS) over the last 5 years, with Q3 2025 value amounting to 0.03%.

  • GeneDx Holdings' Return on Capital Employed rose 2000.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.06% for FY2024, which is 3900.0% up from last year.
  • As of Q3 2025, GeneDx Holdings' Return on Capital Employed stood at 0.03%, which was up 2000.0% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Return on Capital Employed peaked at 0.03% during Q3 2025, and registered a low of 3.39% during Q2 2021.
  • In the last 5 years, GeneDx Holdings' Return on Capital Employed had a median value of 0.78% in 2022 and averaged 0.91%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 25200bps in 2022, then crashed by -8200bps in 2023.
  • Over the past 5 years, GeneDx Holdings' Return on Capital Employed (Quarter) stood at 0.93% in 2021, then plummeted by -39bps to 1.29% in 2022, then skyrocketed by 61bps to 0.5% in 2023, then surged by 87bps to 0.06% in 2024, then skyrocketed by 139bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.01% for Q2 2025, and 0.04% during Q1 2025.